Maxim Group
7
26M
7
0.33
3
4
- Stages of investment
- Areas of investment
Summary
Maxim Group is the famous Corporate Investor, which was founded in 2002. The main department of described Corporate Investor is located in the New York. The venture was found in North America in United States.
Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight ContraFect, Abeona Therapeutics, BillMyParents. We can highlight the next thriving fund investment areas, such as Young Adults, E-Commerce. The fund has no exact preference in some founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager.
The usual cause for the fund is to invest in rounds with 2 partakers. Despite the Maxim Group, startups are often financed by Stop Sanfilippo, George Soros, Equity Source Partners. The meaningful sponsors for the fund in investment in the same round are RBC Capital Markets, Jefferies, H. C. Wainwright & Co.. In the next rounds fund is usually obtained by Venrock, Sofinnova Investments, New Leaf Venture Partners.
The overall number of key employees were 12.
Opposing the other organizations, this Maxim Group works on 11 percentage points more the average amount of lead investments. The high activity for fund was in 2017. The fund is constantly included in less than 2 deals per year. The increased amount of exits for fund were in 2015. Considering the real fund results, this Corporate Investor is 40 percentage points more often commits exit comparing to other organizations. The usual things for fund are deals in the range of 10 - 50 millions dollars.
Investments analytics
Analytics
- Total investments
- 7
- Lead investments
- 3
- Exits
- 4
- Rounds per year
- 0.33
- Investments by industry
- Health Care (5)
- Biotechnology (4)
- Medical (3)
- Medical Device (2)
- Genetics (1) Show 9 more
- Investments by region
-
- United States (6)
- Israel (1)
- Peak activity year
- 2017
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 13
- Group Appearance index
- 0.43
- Avg. company exit year
- 10
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Nacuity Pharmaceuticals | 15 Jun 2022 | Health Care, Pharmaceutical | Early Stage Venture | 16M | United States, Texas, Fort Worth |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.